Blood derivative in-vitro diagnostic substances manufacturing · California
Immuno Concepts, N.A Ltd
Sacramento, CA · ~28 workers · 8 years of OSHA Injury Tracking Application data.
- B
- Good Safety Record
- 1.8
- Avg TCR
- 3.3
- Industry avg
- 0
- Fatalities
The verdict
Immuno Concepts, N.A Ltd runs at 54% of its industry's injury rate - safer than the typical Blood derivative in-vitro diagnostic substances manufacturing workplace, earning a grade B.
Immuno Concepts, N.A Ltd: 1.8 TCR = 54% of Blood derivative in-vitro diagnostic substances manufacturing BLS 3.3 · 8y Form 300A (see methodology below)
Immuno Concepts, N.A Ltd safety composite
Immuno Concepts, N.A Ltd scores strongest on dart rate (safer than 84% of same-industry peers) and weakest on total case rate (tcr) (safer than 36%), blended into one 0-100 breakdown against same-industry peers. A missing measure drops out and redistributes its weight rather than deflating the score. This is a per-dimension breakdown, distinct from the single letter grade above it (which weights TCR alone against the BLS industry benchmark).
56/100
Percentile-weighted across 3 of 3 measures
- Total Case Rate (TCR)
- D 1.79 per 100 workers
Safer than 36% of industry peers
- DART rate
- B 0 per 100 workers
Safer than 84% of industry peers
- Fatalities
- D 0
Safer than 50% of industry peers
Benchmarked live against every credibly-rated employer in the same NAICS industry code in the current OSHA extract (a segment must have at least 8 rated peers to benchmark). Not a legal or compliance determination; PlainSafetyScore's own weighting (TCR 40%, DART 35%, fatalities 25%).
Immuno Concepts, N.A Ltd held a steady TCR band
Immuno Concepts, N.A Ltd's TCR held near 0.0 from 0.0 in 2017 to 0.0 in 2024. Peak filing year was 2018 at 5.7 TCR. In 2024, DART was 0× this establishment's average TCR (severity share of cases).
2017=0.0 · 2018=5.7 · 2019=0.0 · 2020=0.0 · 2021=3.9 · 2022=0.0 · 2023=4.8 · 2024=0.0
OSHA ITA Form 300A scorecard
Establishment book 325413 · Sacramento, CA AT/BELOW-IND · SMALL
Grade B · TCR 1.8 · 54% of ind
- DART 0.0 DART
- RANK #38/50
- PHOTO TriLink Biotechnolog…
- BOOK 8y book
- INJ 4 inj
- SIZE ~28 FTE
Nearest TCR peer: TriLink Biotechnologies LLC (0.0 TCR gap)
Read with this employer → · Industry book → · California employers → · Look up another →
Immuno Concepts, N.A Ltd in the TCR neighbourhood
Average Total Case Rate among this establishment and nearest same-industry peers
- This site
Immuno Concepts, N.A Ltd
1.8 TCR
- TriLink Biotec
TriLink Biotechnologies LLC
1.8 TCR
- Cell Marque Co
Cell Marque Corporation
1.8 TCR
- Cedar Creek
Cedar Creek
1.8 TCR
- Ortho Clinical
Ortho Clinical Diagnostics Raritan
1.8 TCR
What this shows Immuno Concepts, N.A Ltd averages 1.8 TCR (54% of the Blood derivative in-vitro diagnostic substances manufacturing BLS benchmark).
Immuno Concepts, N.A Ltd TCR series: 2017=0 · 2018=5.7 · 2019=0 · 2020=0 · 2021=3.9 · 2022=0 · 2023=4.8 · 2024=0 · BLS 3.3
Where Immuno Concepts, N.A Ltd falls in its industry
201 Blood derivative in-vitro diag establishmentsSafer than 36% of graded establishments in this industry, whose median TCR is 1.4.
Narrower to California alone (the establishments it most directly competes with for workers and contracts): ranked #38 safest of 50 Blood derivative in-vitro diag employers in California.
Immuno Concepts, N.A Ltd has fewer employees than the Blood derivative in-vitro diagnostic sub median and a higher injury rate than the industry's median TCR of 1.4. Workforce size and injury rate do not always move together within the same industry -- some of its smaller peers run higher rates than its larger ones, and vice versa.
Year-by-Year Safety Data
| Year | TCR | DART | Injuries | Illnesses | Fatalities |
|---|---|---|---|---|---|
| 2024 | 0.0 | 0.0 | 0 | 0 | 0 |
| 2023 | 4.8 | 4.8 | 1 | 0 | 0 |
| 2022 | 0.0 | 0.0 | 0 | 0 | 0 |
| 2021 | 3.9 | 0.0 | 1 | 0 | 0 |
| 2020 | 0.0 | 0.0 | 0 | 0 | 0 |
| 2019 | 0.0 | 0.0 | 0 | 0 | 0 |
| 2018 | 5.7 | 5.7 | 2 | 0 | 0 |
| 2017 | 0.0 | 0.0 | 0 | 0 | 0 |
OSHA ITA peer cross-reference
Establishment peer ledger
325413 · CA · Sacramento
201 Blood derivative in-vitro diagnostic substances manufacturing employers nationwide with a credible TCR · 51,834 rated employers in California with headcount on file · 1,348 employers in Sacramento, CA · 4 cross-state NAT-TCR peers · 4 cross-state NAT-SIZE peers. Closest matches by relationship code are listed below.
| Rel | Establishment | Metric |
|---|---|---|
| NAICS-TCR | TriLink Biotechnologies LLC | 1.8 TCR |
| NAICS-TCR | Cell Marque Corporation | 1.8 TCR |
| NAICS-TCR | Cedar Creek | 1.8 TCR |
| NAICS-TCR | Ortho Clinical Diagnostics Raritan | 1.8 TCR |
| STATE-SIZE | Davis Ranch L.L.C. | 28 FTE |
| STATE-SIZE | Steinbeck Country Produce | 28 FTE |
| STATE-SIZE | Harlan Family Ranch | 28 FTE |
| STATE-SIZE | KKG Equipment Company, LLC32 | 28 FTE |
| CITY-NEAR | UC Davis Health | 10,481 FTE |
| CITY-NEAR | Employment Development Department | 8,494 FTE |
| CITY-NEAR | California Department of Transportation Facility 451 | 5,500 FTE |
| CITY-NEAR | California Department of Transportation Facility 485 | 5,500 FTE |
| NAT-TCR | Round Rock TX Millwork | 1.8 TCR |
| NAT-TCR | Aurora Cooperative - Grand Island Agronomy | 1.8 TCR |
| NAT-TCR | Sodexo at Neal Blaisdell Waikiki Shell | 1.8 TCR |
| NAT-TCR | General Landscaping LLC | 1.8 TCR |
| NAT-SIZE | Sunray Printing Solutions Inc | 28 FTE |
| NAT-SIZE | Hartford South | 28 FTE |
| NAT-SIZE | Bus Garage | 28 FTE |
| NAT-SIZE | District Wide | 28 FTE |
Rel codes: NAICS-TCR · STATE-SIZE · CITY-NEAR · NAT-TCR/NAT-SIZE cross-state. Read with this employer →
Read our methodology - how this data is sourced, computed, and verified.